Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06506539Phase 2Completed
Phase 2, randomised, open-label trial of LAENNEC in periodontitis (2 arms), sponsored by Suez Canal University. Primary endpoints: Plaque Index at 3 months, Gingival Index at 3 months and 2 more. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06506539.